Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population
Sponsor: University of Alberta
Summary
This is a multi-centre, randomised controlled trial comparing fecal microbiota transplantation to placebo in an expanded ulcerative colitis population: a feasibility study (FRONTIER-UC) to determine whether a full-scale randomized controlled trial (RCT) to investigate fecal microbiota transplantation (FMT) in ulcerative colitis (UC) is feasible.
Official title: A Multi-centre, Randomised Controlled Trial Comparing Fecal Microbiota Transplantation to Placebo in an Expanded Ulcerative Colitis Population: a Feasibility Study (FRONTIER-UC)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
85
Start Date
2026-03-01
Completion Date
2028-12-01
Last Updated
2026-02-10
Healthy Volunteers
No
Interventions
Lyophilized Fecal Microbiota Transplantation (LFMT)
LFMT by oral capsules
Placebo
Placebo capsules does not contain FMT
Locations (2)
University of Calgary
Calgary, Alberta, Canada
University of Alberta
Edmonton, Alberta, Canada